| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/28/2005 | CA2542329A1 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer |
| 04/28/2005 | CA2542290A1 Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof |
| 04/28/2005 | CA2541264A1 Breast cancer treatment regimen |
| 04/27/2005 | EP1526141A2 MHC complexes and uses thereof |
| 04/27/2005 | EP1526140A1 Novel potassium-dependent sodium-calcium exchanger |
| 04/27/2005 | EP1526134A2 Triazolyl tropane derivatives as ccr5 modulators |
| 04/27/2005 | EP1526133A1 Epothilone derivatives |
| 04/27/2005 | EP1526132A2 Substituted oxazolidinone derivatives and their use as factor xa inhibitors |
| 04/27/2005 | EP1525884A1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525882A1 Administration form comprising an acid-labile active compound |
| 04/27/2005 | EP1525323A2 Pgc-beta, a novel pgc-1 homologue and uses therefor |
| 04/27/2005 | EP1525313A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 04/27/2005 | EP1525312A2 Brachyspira hyodysenteriae vaccine |
| 04/27/2005 | EP1525308A2 Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 04/27/2005 | EP1525307A2 Modified adamts4 molecules and method of use thereof |
| 04/27/2005 | EP1525306A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 04/27/2005 | EP1525209A2 1'-, 2'- and 3' -modified nucleoside derivatives for treating flaviviridae infections |
| 04/27/2005 | EP1525204A1 Phenylalanine enamide derivatives |
| 04/27/2005 | EP1525200A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/27/2005 | EP1525199A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 04/27/2005 | EP1525191A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525018A1 Medicament dispenser |
| 04/27/2005 | EP1525001A1 Conjugates of porphyrin compounds with chemotherapeutic agents |
| 04/27/2005 | EP1525000A2 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1524996A2 Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
| 04/27/2005 | EP1524995A1 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas |
| 04/27/2005 | EP1524984A1 Myocardial perfusion imaging using a2a receptor agonists |
| 04/27/2005 | EP1524977A2 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 04/27/2005 | EP1524975A1 Improved transdermal delivery system for the administration of rotigotine |
| 04/27/2005 | EP1524971A1 Improved transdermal delivery system |
| 04/27/2005 | EP1524912A1 Compositions comprising lactoferrin |
| 04/27/2005 | EP1424996B1 Method for the production of inhalation powders |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1366033B1 Chemical compounds |
| 04/27/2005 | EP1363614B1 Use of 2-amino-1-(4-hydroxy-3-methanesulphonamidophenyl)ethanol for treating urinary incontinence |
| 04/27/2005 | EP1261327B1 Adenosine receptor modulators |
| 04/27/2005 | EP1244662B1 Pyridazino quinoline derivative and method for the treatment of pain |
| 04/27/2005 | EP1144411B1 Antihistaminic spiro compounds |
| 04/27/2005 | EP1139974A4 Soy depigmenting and skin care compositions |
| 04/27/2005 | EP1105122B1 Pharmaceutical compositions containing lipase inhibitors |
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |
| 04/27/2005 | EP1033997B1 Method of mobilizing hematopoietic stem cells |
| 04/27/2005 | EP1015019B1 Compositions and methods of therapy for igf-i-responsive conditions |
| 04/27/2005 | EP0994853B1 A monoether of probucol and methods for the inhibition of the expression of vcam-1 |
| 04/27/2005 | EP0918515B1 USE OF INHIBITORS OF THE CELLULAR Na+ /H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS |
| 04/27/2005 | EP0906307B1 Substituted imidazoles having cytokine inhibitory activity |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610755A Methods of profiling gene expression, protein or metabolite levels |
| 04/27/2005 | CN1610751A Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 04/27/2005 | CN1610743A Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/27/2005 | CN1610696A Antibodies that immunospecifically bind to TRAIL receptors |
| 04/27/2005 | CN1610695A Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 04/27/2005 | CN1610691A 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 04/27/2005 | CN1610683A Pyrimidotriazines as phosphatase inhibitors |
| 04/27/2005 | CN1610681A Polycyclic compounds having anti-tumor activity |
| 04/27/2005 | CN1610675A Benzothiazole- and benzoxazole-4, 7-dione derivatives and their use as CDC25 phosphatase inhibitors |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610670A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/27/2005 | CN1610669A Heteroaryl-substituted aminocyclohexane derivatives |
| 04/27/2005 | CN1610666A Benzamidine derivative |
| 04/27/2005 | CN1610664A 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 04/27/2005 | CN1610661A Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/27/2005 | CN1610659A Carboxylic acid derivative |
| 04/27/2005 | CN1610560A Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 04/27/2005 | CN1610557A 6-fluorobicyclo 3.1.0 hexane derivatives |
| 04/27/2005 | CN1610549A Epermycin derivative for treating difficult to cure tumor |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1610545A Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor |
| 04/27/2005 | CN1610543A Use of N, N-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy |
| 04/27/2005 | CN1610542A New use for the treatment of gastroesophageal reflux disease |
| 04/27/2005 | CN1610539A Pharmaceutical composition comprising a 5HT1 receptor agonist |
| 04/27/2005 | CN1610502A Surfactant protein for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2005 | CN1609086A MPTP affinity labels |
| 04/27/2005 | CN1608670A Refreshing capsule and its prepn process |
| 04/27/2005 | CN1608649A Chinese medicine health tonic for raising antisenility capacity and improving memory |
| 04/27/2005 | CN1608646A Wolfberry fruit-astragalus root oral liquid and its prepn process |
| 04/27/2005 | CN1608640A Medicated wine for treating senile disease and its prepn process |
| 04/27/2005 | CN1608617A Application of levocarnitine and its derivative in preventing and treating high altitude diseases |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198929C Antibodies against interferon alpha/beta receptor |
| 04/27/2005 | CN1198834C Water soluble produgs of hindered alcohols or phenols |
| 04/27/2005 | CN1198832C New amino propylphosphinic acid |
| 04/27/2005 | CN1198827C Selected derivatives of K-252a |
| 04/27/2005 | CN1198821C Process for preparation of sulfonamide derivs. and crystals thereof |
| 04/27/2005 | CN1198819C Benzimidazole derivatives |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198816C Farnesyl protein transferase inhibitors |
| 04/27/2005 | CN1198814C Salt |
| 04/27/2005 | CN1198807C 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical composition containing the same |
| 04/27/2005 | CN1198803C Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 04/27/2005 | CN1198802C Chalcones having antiproliferactive activity |
| 04/27/2005 | CN1198801C Indole derivatives |
| 04/27/2005 | CN1198654C Pharmaceutical complex |
| 04/27/2005 | CN1198647C Antibodies against human CD40 |
| 04/27/2005 | CN1198641C Antistress agents and functional foods |